BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $379,175,208 | -5.9% | 7,439,184 | -0.5% | 0.09% | -15.0% |
| Q3 2022 | $402,831,166 | -4.8% | 7,479,227 | +13.5% | 0.11% | -1.8% |
| Q2 2022 | $423,155,397 | -4.1% | 6,588,127 | +15.8% | 0.11% | +13.5% |
| Q1 2022 | $441,280,373 | -7.4% | 5,691,003 | +2.5% | 0.10% | -2.0% |
| Q4 2021 | $476,431,000 | +5.0% | 5,550,220 | -1.7% | 0.10% | -2.0% |
| Q3 2021 | $453,927,000 | -0.5% | 5,643,756 | -0.4% | 0.10% | +1.0% |
| Q2 2021 | $456,293,000 | -8.7% | 5,668,231 | -4.4% | 0.10% | -13.2% |
| Q1 2021 | $499,816,000 | +5.2% | 5,926,198 | +0.1% | 0.11% | +2.7% |
| Q4 2020 | $474,893,000 | +0.1% | 5,918,405 | +0.4% | 0.11% | -11.9% |
| Q3 2020 | $474,216,000 | -5.6% | 5,896,743 | +1.0% | 0.13% | -13.1% |
| Q2 2020 | $502,514,000 | +13.3% | 5,836,398 | +6.8% | 0.14% | -8.2% |
| Q1 2020 | $443,497,000 | -25.4% | 5,462,455 | -23.2% | 0.16% | -4.8% |
| Q4 2019 | $594,377,000 | -1.7% | 7,108,075 | +2.8% | 0.17% | -10.3% |
| Q3 2019 | $604,898,000 | +21.1% | 6,915,490 | +13.4% | 0.18% | +20.1% |
| Q2 2019 | $499,383,000 | -28.4% | 6,097,463 | -28.9% | 0.15% | -31.6% |
| Q1 2019 | $697,688,000 | +27.0% | 8,580,605 | +2.8% | 0.22% | +10.3% |
| Q4 2018 | $549,458,000 | -4.0% | 8,347,905 | +12.4% | 0.20% | +9.7% |
| Q3 2018 | $572,296,000 | +2.8% | 7,423,753 | -1.5% | 0.19% | -2.6% |
| Q2 2018 | $556,506,000 | +18.5% | 7,536,644 | +4.4% | 0.19% | +12.4% |
| Q1 2018 | $469,450,000 | -4.7% | 7,217,856 | -5.3% | 0.17% | -4.0% |
| Q4 2017 | $492,641,000 | -10.9% | 7,621,301 | -13.5% | 0.18% | -15.7% |
| Q3 2017 | $552,766,000 | +1.8% | 8,809,022 | -1.8% | 0.21% | -2.8% |
| Q2 2017 | $543,182,000 | +20.4% | 8,972,287 | +3.2% | 0.22% | +16.8% |
| Q1 2017 | $450,972,000 | +10.3% | 8,695,958 | -5.7% | 0.18% | +3.4% |
| Q4 2016 | $408,956,000 | -1.1% | 9,223,176 | +1.4% | 0.18% | -8.7% |
| Q3 2016 | $413,687,000 | +2.7% | 9,099,367 | +2.1% | 0.20% | +2.6% |
| Q2 2016 | $402,879,000 | +89.3% | 8,909,305 | +72.0% | 0.19% | +81.9% |
| Q1 2016 | $212,781,000 | +12.3% | 5,179,669 | +4.3% | 0.10% | +11.7% |
| Q4 2015 | $189,422,000 | +8.3% | 4,965,211 | -6.8% | 0.09% | +2.2% |
| Q3 2015 | $174,966,000 | -49.5% | 5,326,197 | +7.4% | 0.09% | -46.8% |
| Q2 2015 | $346,750,000 | +8.5% | 4,958,533 | +6.3% | 0.17% | +10.2% |
| Q1 2015 | $319,662,000 | +5.2% | 4,666,600 | +12.6% | 0.16% | +1.9% |
| Q4 2014 | $303,788,000 | +5.4% | 4,145,011 | +3.2% | 0.15% | -1.3% |
| Q3 2014 | $288,202,000 | -50.2% | 4,015,644 | -49.8% | 0.16% | 0.0% |
| Q2 2014 | $578,706,000 | +96.5% | 8,004,224 | +100.0% | 0.16% | -6.0% |
| Q1 2014 | $294,475,000 | +5.8% | 4,002,112 | 0.0% | 0.17% | +3.8% |
| Q4 2013 | $278,347,000 | -3.2% | 4,002,112 | -8.5% | 0.16% | -4.8% |
| Q3 2013 | $287,463,000 | -6.5% | 4,376,050 | -1.4% | 0.17% | -12.0% |
| Q2 2013 | $307,543,000 | -4.4% | 4,439,783 | +0.3% | 0.19% | -8.6% |
| Q1 2013 | $321,670,000 | +23.0% | 4,428,265 | +2.1% | 0.21% | +18.8% |
| Q3 2012 | $261,430,000 | +4.2% | 4,338,369 | +1.2% | 0.18% | -12.4% |
| Q2 2012 | $250,860,000 | – | 4,287,473 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |